LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.97 | 17.25 | 868 | 5618 | 0.1545 | 0.5990 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.97 | 17.25 | 886 | 5618 | 0.1577 | 0.6030 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.97 | 17.25 | 53 | 5618 | 0.0094 | 0.1439 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.97 | 17.25 | 1052 | 5618 | 0.1872 | 0.6363 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.94 | 17.25 | 879 | 5681 | 0.1547 | 0.6000 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.94 | 17.25 | 898 | 5681 | 0.1581 | 0.6041 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.94 | 17.25 | 58 | 5681 | 0.0102 | 0.1560 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.94 | 17.25 | 1117 | 5681 | 0.1966 | 0.6465 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 78.91 | 17.25 | 871 | 5730 | 0.1520 | 0.5972 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 78.91 | 17.25 | 889 | 5730 | 0.1551 | 0.6011 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 78.91 | 17.25 | 61 | 5730 | 0.0106 | 0.1628 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 78.91 | 17.25 | 1045 | 5730 | 0.1824 | 0.6323 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 80.88 | 17.25 | 869 | 5826 | 0.1492 | 0.5946 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 80.88 | 17.25 | 889 | 5826 | 0.1526 | 0.5989 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 80.88 | 17.25 | 64 | 5826 | 0.0110 | 0.1689 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 80.88 | 17.25 | 1145 | 5826 | 0.1965 | 0.6478 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 82.85 | 17.25 | 863 | 5861 | 0.1472 | 0.5925 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 82.85 | 17.25 | 882 | 5861 | 0.1505 | 0.5966 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 82.85 | 17.25 | 62 | 5861 | 0.0106 | 0.1643 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 82.85 | 17.25 | 1023 | 5861 | 0.1745 | 0.6250 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 84.82 | 17.25 | 885 | 5924 | 0.1494 | 0.5959 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 84.82 | 17.25 | 900 | 5924 | 0.1519 | 0.5991 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 84.82 | 17.25 | 57 | 5924 | 0.0096 | 0.1524 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 84.82 | 17.25 | 1281 | 5924 | 0.2162 | 0.6675 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 86.79 | 17.25 | 880 | 6008 | 0.1465 | 0.5931 | MN20160310_N02 | D08 |